COST-UTILITY ANALYSIS OF DONEPEZIL FOR THE TREATMENT OF ALZHEIMER'S DISEASE IN THAILAND

被引：0
|
作者：
Permsuwan, U. [1 ]
Niwatananun, W. [1 ]
Pimkrai, A. [2 ]
机构：
[1] Chiang Mai Univ, Chiang Mai 50000, Thailand
[2] Chiang Mai Neurol Hosp, Chiang Mai, Thailand
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.268
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A648 / A648
页数：1
相关论文
共 50 条
  • [1] EVOLUTION OF A COST-UTILITY MODEL OF DONEPEZIL FOR ALZHEIMER'S DISEASE
    Peters, Jaime L.
    Anderson, Rob
    Hoyle, Martin
    Hyde, Chris
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2013, 29 (02) : 147 - 154
  • [2] COST-UTILITY ANALYSIS OF CHOLINESTERASE INHIBITORS IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE
    Turongkaravee, S.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A502 - A502
  • [3] COST-UTILITY ANALYSIS OF MULTIPLE SCLEROSIS TREATMENT IN THAILAND
    Chanatittarat, Chalakorn
    Chaikledkaew, Usa
    Prayoonwiwat, Naraporn
    Siritho, Sasitorn
    Pasogpakdee, Pakamas
    Apiwattanakul, Metha
    Riewpaiboon, Arthorn
    Thavorncharoensap, Montarat
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (06) : 584 - 592
  • [4] A Cost-Utility Analysis of Rivastigmine Transdermal System for the Treatment of Patients with Alzheimer's Disease in Mexico
    Cruz, Samaria
    Briones, Bernardo
    Garcia-Contreras, Fernando
    [J]. NEUROLOGY, 2011, 76 (09) : A231 - A231
  • [5] Treatment costs in Hodgkin's disease: A cost-utility analysis
    Norum, J
    Angelsen, V
    Wist, E
    Olsen, JA
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (09) : 1510 - 1517
  • [6] The cost-effectiveness of donepezil and rivastigmine in the treatment of Alzheimer's disease in Thailand private hospital
    Pattanaprateep, O
    Phongchareonsuk, P
    Chaikledkaew, U
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 314 - 315
  • [7] COST-UTILITY ANALYSIS OF ROPINIROLE IN PARKINSON'S DISEASE (PD) TREATMENT
    Zerda, I
    Drozdz, A.
    Brzyski, D.
    Pochopien, M.
    Gwiosda, B.
    Lisiecka, B.
    Barlog, D.
    Glogowski, C.
    Dziurda, D.
    Rys, P.
    Plisko, R.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A323 - A323
  • [8] Is donepezil cost-effective in the treatment of Alzheimer's disease?
    Sobolewski, M
    Kuzniar, J
    Splawinski, J
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S97 - S97
  • [9] COST-UTILITY ANALYSIS OF HERPES ZOSTER VACCINE IN THAILAND
    Taychakhoonavudh, S.
    Suranant, N.
    Issarasenee, K.
    Laoprasertsuk, C.
    Jiamton, S.
    Chanyachailert, P.
    Leeyaphan, C.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A808 - A808
  • [10] Cost-Utility Analysis of Intravenous Immunoglobulin for the Treatment of Steroid-Refractory Dermatomyositis in Thailand
    Bamrungsawad, Naruemon
    Chaiyakunapruk, Nathorn
    Upakdee, Nilawan
    Pratoomsoot, Chayanin
    Sruamsiri, Rosarin
    Dilokthornsakul, Piyameth
    [J]. PHARMACOECONOMICS, 2015, 33 (05) : 521 - 531
12345